Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 1
1992 3
1993 4
1994 2
1995 2
1996 6
1997 3
1998 5
1999 5
2000 3
2001 4
2002 8
2003 5
2004 8
2005 3
2006 3
2007 15
2008 13
2009 14
2010 9
2011 16
2012 10
2013 12
2014 19
2015 30
2016 18
2017 19
2018 19
2019 21
2020 29
2021 22
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

313 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Lee LA, Bailes Z, Barnes N, Boulet LP, Edwards D, Fowler A, Hanania NA, Kerstjens HAM, Kerwin E, Nathan R, Oppenheimer J, Papi A, Pascoe S, Brusselle G, Peachey G, Sule N, Tabberer M, Pavord ID. Lee LA, et al. Among authors: kerstjens ham. Lancet Respir Med. 2021 Jan;9(1):69-84. doi: 10.1016/S2213-2600(20)30389-1. Epub 2020 Sep 9. Lancet Respir Med. 2021. PMID: 32918892 Clinical Trial.
Sputum microbiome profiling in COPD: beyond singular pathogen detection.
Ditz B, Christenson S, Rossen J, Brightling C, Kerstjens HAM, van den Berge M, Faiz A. Ditz B, et al. Among authors: kerstjens ham. Thorax. 2020 Apr;75(4):338-344. doi: 10.1136/thoraxjnl-2019-214168. Epub 2020 Jan 29. Thorax. 2020. PMID: 31996401 Free PMC article. Review.
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Kerstjens HAM, Maspero J, Chapman KR, van Zyl-Smit RN, Hosoe M, Tanase AM, Lavecchia C, Pethe A, Shu X, D'Andrea P; IRIDIUM trial investigators. Kerstjens HAM, et al. Lancet Respir Med. 2020 Oct;8(10):1000-1012. doi: 10.1016/S2213-2600(20)30190-9. Epub 2020 Jul 9. Lancet Respir Med. 2020. PMID: 32653074 Clinical Trial.
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S, Lugogo N, Martinot JB, Sagara H, Albers FC, Bradford ES, Harris SS, Mayer B, Rubin DB, Yancey SW, Sciurba FC. Pavord ID, et al. Among authors: kerstjens ham. N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11. N Engl J Med. 2017. PMID: 28893134 Free article. Clinical Trial.
Tiotropium in asthma poorly controlled with standard combination therapy.
Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, Bateman ED. Kerstjens HA, et al. N Engl J Med. 2012 Sep 27;367(13):1198-207. doi: 10.1056/NEJMoa1208606. Epub 2012 Sep 2. N Engl J Med. 2012. PMID: 22938706 Free article. Clinical Trial.
Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial.
Duiverman ML, Vonk JM, Bladder G, van Melle JP, Nieuwenhuis J, Hazenberg A, Kerstjens HAM, van Boven JFM, Wijkstra PJ. Duiverman ML, et al. Among authors: kerstjens ham. Thorax. 2020 Mar;75(3):244-252. doi: 10.1136/thoraxjnl-2019-213303. Epub 2019 Sep 4. Thorax. 2020. PMID: 31484786 Free PMC article. Clinical Trial.
Bronchiectasis.
Ten Hacken NH, Kerstjens HA. Ten Hacken NH, et al. Among authors: kerstjens ha. BMJ Clin Evid. 2011 Aug 16;2011:1507. BMJ Clin Evid. 2011. PMID: 21846412 Free PMC article. Review.
Copd.
Kerstjens HA, Postma DS, Ten Hacken N. Kerstjens HA, et al. BMJ Clin Evid. 2008 Dec 15;2008:1502. BMJ Clin Evid. 2008. PMID: 19445783 Free PMC article. Review.
[COPD: working with treatable traits].
van Dijk M, Sachs APE, Kerstjens HAM. van Dijk M, et al. Among authors: kerstjens ham. Ned Tijdschr Geneeskd. 2021 Apr 29;165:D5326. Ned Tijdschr Geneeskd. 2021. PMID: 34346592 Review. Dutch.
313 results